دورية أكاديمية

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

التفاصيل البيبلوغرافية
العنوان: Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
المؤلفون: James Larkin, Jeffrey Weber, Victoria Atkinson, Michael Millward, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Helen Gogas, Paolo A Ascierto, Anna Maria Di Giacomo, Veerle de Pril, Vanna Chiarion-Sileni, Stephane Dalle, Leslie Fecher, Ana Arance, Jean-Jacques Grob, Nikhil I Khushalani, Michele Del Vecchio, Mario Mandala, C Lance Cowey, Michael Schenker, Petr Arenberger, Maurice Lobo
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
بيانات النشر: BMJ Publishing Group, 2021.
سنة النشر: 2021
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2051-1426
العلاقة: https://jitc.bmj.com/content/9/8/e003188.fullTest; https://doaj.org/toc/2051-1426Test
DOI: 10.1136/jitc-2021-003188
الوصول الحر: https://doaj.org/article/c281f8a682984c818531f79c5352985aTest
رقم الانضمام: edsdoj.281f8a682984c818531f79c5352985a
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20511426
DOI:10.1136/jitc-2021-003188